broadspectrum anticonvulsant drug currently development janssen pharmaceutica secondgeneration followup marketed drug designed anticonvulsant effects topiramate without side effects associated topiramates carbonic anhydrase also potential use treatment inflammatory pain neuropathic pain entered phase ii clinical trials october metabolites radioactive isotopelabeled derivatives also prepared support